These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7353752)

  • 1. Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy.
    Morgan MY; Jakobovits AW; James IM; Sherlock S
    Gastroenterology; 1980 Apr; 78(4):663-70. PubMed ID: 7353752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of bromocriptine in the treatment of a patient with chronic portasystemic encephalopathy.
    Morgan MY; Jakobovits A; Elithorn A; James IM; Sherlock S
    N Engl J Med; 1977 Apr; 296(14):793-4. PubMed ID: 576493
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial.
    Uribe M; Farca A; Márquez MA; Garcĭa-Ramos G; Guevara L
    Gastroenterology; 1979 Jun; 76(6):1347-51. PubMed ID: 374177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
    Riggio O; Balducci G; Ariosto F; Merli M; Tremiterra S; Ziparo V; Capocaccia L
    Hepatogastroenterology; 1990 Oct; 37(5):524-7. PubMed ID: 2253931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of acute and chronic hepatic encephalopathy in cirrhosis].
    Doffoel M; Bockel R
    Ann Gastroenterol Hepatol (Paris); 1984; 20(3):163-6. PubMed ID: 6529174
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography].
    Bello Mimbrera G; García de León M; de la Torre Gutiérrez S; Montero Vázquez J; Torres Salcines J; de la Torre Fernández JM
    Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):277-9. PubMed ID: 2499914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
    Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral blood flow and metabolism in patients with chronic liver disease undergoing orthotopic liver transplantation.
    Philips BJ; Armstrong IR; Pollock A; Lee A
    Hepatology; 1998 Feb; 27(2):369-76. PubMed ID: 9462633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].
    Chen MF; Li RC; Chen CH; Gao XC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):718-9, 722. PubMed ID: 15958319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies].
    Boca M; Vyskocil M; Mikulecký M; Ebringer L; Kolibás E; Kratochvíl'ová H; Buzgová D
    Cas Lek Cesk; 2004; 143(5):324-8. PubMed ID: 15305769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
    Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G
    Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.
    Strauss E; Tramote R; Silva EP; Caly WR; Honain NZ; Maffei RA; de Sá MF
    Hepatogastroenterology; 1992 Dec; 39(6):542-5. PubMed ID: 1483668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of bromocriptine in the treatment of chronic hepatic encephalopathy].
    Pascual Izuel JM; Peces Serrano R; Hernández Guio C
    Rev Clin Esp; 1979 Nov; 155(3):219-21. PubMed ID: 397554
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.
    Lockwood AH; Yap EW; Wong WH
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):337-41. PubMed ID: 1997506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard and higher doses of bromocriptine for severe chronic portal-systemic encephalopathy.
    Uribe M; García-Ramos G; Ramos M; Valverde C; Márquez MA; Farca A; Guevara L
    Am J Gastroenterol; 1983 Aug; 78(8):517-22. PubMed ID: 6881119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic blood flow and splanchnic oxygen consumption in patients with liver failure. Effect of high-volume plasmapheresis.
    Clemmesen JO; Gerbes AL; Gülberg V; Hansen BA; Larsen FS; Skak C; Tygstrup N; Ott P
    Hepatology; 1999 Feb; 29(2):347-55. PubMed ID: 9918909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral blood flow and metabolism in fulminant liver failure.
    Wendon JA; Harrison PM; Keays R; Williams R
    Hepatology; 1994 Jun; 19(6):1407-13. PubMed ID: 8188170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.